RT Journal Article SR Electronic(1) A1 Omer Ibrahim Abdalla, Eynas A1 Nahid, Seema A1 Shastham Valappil, Sikha A1 Gudavalli, Srinivas A1 Sellami, Soumaya A1 Korichi, Noureddine A1 Ahmad, Shamsa A1 Vicente Canizares Cespedes, Victor A1 Gopalakrishnan, SanthoshYR 2022 T1 Impact of COVID-19 status on patients receiving neuraxial analgesia during labor: A national retrospective-controlled study JF Qatar Medical Journal, VO 2022 IS 3 OP SP 30 DO https://doi.org/10.5339/qmj.2022.30 PB Hamad bin Khalifa University Press (HBKU Press), SN 2227-0426, AB Background: Pregnancy affects a woman's susceptibility to and severity of certain infectious diseases. Central neuraxial block for analgesia during labor is superior to nonneuraxial methods in efficacy, safety, and maternal satisfaction. Although Coronavirus disease (COVID-19) can be vertically transmitted from mother to fetus, little is known about the effects of COVID-19 on pregnant women or about anesthesia management and the risk of adverse effects related to neuraxial techniques in women with untreated COVID-19 during gestation. Aim: This investigation assesses the effects of neuraxial analgesia during labor of COVID-19-positive parturients on their hemodynamic stability. Results: The study was conducted on 64 patients and involved 32 parturients positive for SARS-CoV-2 by polymerase chain reaction (PCR) and a similar number of control “negative” patients. The affected group had an uneventful course during gestation. Seven were positive for ground-glass opacities on chest X-rays, and none underwent computed tomography (CT) scans. Two neonates were PCR-positive for SARS-CoV-2, and all 32 neonates were released from the hospital. No clinical differences were observed between the neonates in the COVID-19 and control groups. Although parturients in both groups were hemodynamically stable, hemodynamic stability was subnormal in the COVID-19 group regarding blood pressure, oxygen saturation, heart rate, and body temperature. None of the women in either group required a vasopressor or oxygen supplementation during delivery. No other clinical differences were observed between the COVID-19 and control groups. Conclusion: This is the first case-controlled study testing the anesthetic implications of neuraxial labor analgesia in pregnant, COVID-19-positive women. Although management of neuraxial labor analgesia did not differ in pregnant women positive and negative for COVID-19, their hemodynamic characteristics differed significantly. Therefore, care is required to prevent adverse outcomes in pregnant women positive for COVID-19., UL https://www.qscience.com/content/journals/10.5339/qmj.2022.30